RecruitingMontalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic DiseaseThe Montalcino Aortic Consortium (MAC) will provide the infrastructure to assemble large cohorts of patients with mutations in known heritable thoracic aortic disease (H-TAD) genes, define the phenotype associated with these genes, and determine genetic and environmental modifiers of H-TAD.